Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Intrathecal Dexmedetomidine as an Adjuvant to Low Dose Hyperbaric 0.5% Bupivacaine on Hemodynamic Parameters in Patients Undergoing Transurethral Resection of the Prostate

NCT05993975 is registered in ClinicalTrials.gov with Sindh Institute of Urology and Transplantation as lead sponsor.

NCT NCT05993975
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05993975 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Intrathecal Dexmedetomidine as an Adjuvant to Low Dose Hyperbaric 0.5% Bupivacaine on Hemodynamic Parameters in Patients Undergoing Transurethral Resection of the Prostate
Lead sponsor
Sindh Institute of Urology and Transplantation
Phase
Phase 4
Overall status
Completed
Start date
July 20, 2021
Completion date
February 18, 2022
Enrollment
108 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post operative pain